HowardColmanMDPhD, FAAN

Summary

• HOWARD COLMAN, MD, PHD. (Updated September 2021)
  SELECTED KEY APPOINTMENTS:
  Jon M. Huntsman Presidential Chair of Neuro-Oncology
  Professor, Depts. of Neurosurgery, Neurology, and Internal Medicine (Oncology), Univ. of Utah
  Investigator, Huntsman Cancer Institute
  Co-Leader, Experimental Therapeutics Program
  Co-Leader, Neurologic Cancers Center, Huntsman Cancer Institute
  
  Dr. Howard Colman is a Professor (Tenured) in the Depts. of Neurosurgery, Neurology, and Internal Medicine (Oncology). He is Leader of the Center for Neurologic Cancers at HCI. He is also former Medical Director of Neuro-Oncology at Intermountain Medical Center, and former Acting Chair of Hematology and Oncology at the Salt Lake City VA Hospital. Dr. Colman received his M.D. and a Ph.D. in Neuroscience from Washington University School of Medicine in St. Louis, Missouri. He completed a Neuro-Oncology fellowship at the UT MD Anderson Cancer Center in Houston, Texas and is board-certified in Neurology and Neuro-Oncology. Dr. Colman divides his time between patient care and clinical and laboratory research. Dr. Colman's clinical interests are treatment of primary and metastatic brain tumors and diagnosis and management of neurologic complications of cancer. His clinical research is focused on developing and testing new therapies for brain tumors. His laboratory interests are identification of molecular markers of prognosis and treatment response in brain tumors, and the role of tumor stem cells in the development and treatment of resistance of brain tumors. Dr. Colman has been PI and co-investigator on multiple brain tumor clinical trials and grants. Dr. Colman is currently the HCI P.I. for the Alliance for Clinical Trials in Oncology cooperative group, a member of the Board of Directors for Alliance, and a member of the Neuro-Oncology Committee for Alliance. He is a member of the steering committee for the HCI U10 cooperative groups grant. He has served as PI, Co-I, or Project Leader on mul